| REG |
Report |
Q2 2026 Nareit FFO/share |
IN-LINE |
pred ~$1.20 vs. cons $1.19 |
MEDIUM |
| REG |
Report |
Q2 2026 same-property NOI growth |
BEAT |
pred ~2.3% vs. cons 2.2% |
MEDIUM |
| REG |
Report |
Q2 2026 blended cash leasing spreads |
BEAT |
pred ~11.8% vs. cons 11.0% |
MEDIUM |
| REG |
Guide |
Nareit FFO/share guidance |
UNCHANGED |
guide ~$4.85 vs. cons $4.86 (FY2026) |
MEDIUM |
| REG |
Guide |
Core operating earnings/share guidance |
UNCHANGED |
guide ~$4.61 vs. cons $4.62 (FY2026) |
MEDIUM |
| REG |
Guide |
Same-property NOI growth guidance |
UNCHANGED |
guide ~3.50% vs. cons 3.55% (FY2026) |
MEDIUM |
| REG |
Guide |
Development and redevelopment spending guidance |
UNCHANGED |
guide ~$350M vs. cons $350M (FY2026) |
MEDIUM |
| REG |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.1% |
— |
MEDIUM |
| REG |
Return |
5-day cumulative residual |
-0.4% (FADE) |
Day-1 residual of ~-1.1% fades toward a ~-0.4% five-day residual: strong leasing and a modest NOI beat support fundamentals, but unchanged FY2026 FFO guidance of ~$4.85 versus $4.86 consensus leaves little positive out-period revision math after the stock's pre-earnings appreciation. |
MEDIUM |